593 related articles for article (PubMed ID: 7684411)
1. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
[TBL] [Abstract][Full Text] [Related]
2. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells.
Law CL; Aruffo A; Chandran KA; Doty RT; Clark EA
J Immunol; 1995 Oct; 155(7):3368-76. PubMed ID: 7561031
[TBL] [Abstract][Full Text] [Related]
3. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
Engel P; Wagner N; Miller AS; Tedder TF
J Exp Med; 1995 Apr; 181(4):1581-6. PubMed ID: 7535343
[TBL] [Abstract][Full Text] [Related]
4. The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion.
Stamenkovic I; Seed B
Nature; 1990 May; 345(6270):74-7. PubMed ID: 1691828
[TBL] [Abstract][Full Text] [Related]
5. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.
Poe JC; Fujimoto Y; Hasegawa M; Haas KM; Miller AS; Sanford IG; Bock CB; Fujimoto M; Tedder TF
Nat Immunol; 2004 Oct; 5(10):1078-87. PubMed ID: 15378059
[TBL] [Abstract][Full Text] [Related]
6. Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22.
DiJoseph JF; Popplewell A; Tickle S; Ladyman H; Lawson A; Kunz A; Khandke K; Armellino DC; Boghaert ER; Hamann P; Zinkewich-Peotti K; Stephens S; Weir N; Damle NK
Cancer Immunol Immunother; 2005 Jan; 54(1):11-24. PubMed ID: 15693135
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the expression and gene promoter of CD22 in murine B cells.
Andersson KB; Draves KE; Magaletti DM; Fujioka S; Holmes KL; Law CL; Clark EA
Eur J Immunol; 1996 Dec; 26(12):3170-8. PubMed ID: 8977319
[TBL] [Abstract][Full Text] [Related]
8. Organization of the murine Cd22 locus. Mapping to chromosome 7 and characterization of two alleles.
Law CL; Torres RM; Sundberg HA; Parkhouse RM; Brannan CI; Copeland NG; Jenkins NA; Clark EA
J Immunol; 1993 Jul; 151(1):175-87. PubMed ID: 8100843
[TBL] [Abstract][Full Text] [Related]
9. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
10. CD22 regulates thymus-independent responses and the lifespan of B cells.
Otipoby KL; Andersson KB; Draves KE; Klaus SJ; Farr AG; Kerner JD; Perlmutter RM; Law CL; Clark EA
Nature; 1996 Dec 19-26; 384(6610):634-7. PubMed ID: 8967951
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway.
Kansas GS; Tedder TF
J Immunol; 1991 Dec; 147(12):4094-102. PubMed ID: 1721639
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the tyrosine kinase-dependent adhesion pathway in human lymphocytes through CD45.
Wagner N; Engel P; Tedder TF
J Immunol; 1993 Jun; 150(11):4887-99. PubMed ID: 7684415
[TBL] [Abstract][Full Text] [Related]
13. Engagement of the CD45 molecule induces homotypic adhesion of human thymocytes through a LFA-1/ICAM-3-dependent pathway.
Bernard G; Zoccola D; Ticchioni M; Breittmayer JP; Aussel C; Bernard A
J Immunol; 1994 Jun; 152(11):5161-70. PubMed ID: 8189044
[TBL] [Abstract][Full Text] [Related]
14. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
Nadler MJ; McLean PA; Neel BG; Wortis HH
J Immunol; 1997 Nov; 159(9):4233-43. PubMed ID: 9379018
[TBL] [Abstract][Full Text] [Related]
15. CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells.
Barrett TB; Shu G; Clark EA
J Immunol; 1991 Mar; 146(6):1722-9. PubMed ID: 1706378
[TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody against a novel 20-kDa protein induces cell adhesion and cytoskeleton-dependent morphologic changes.
Lin SL; Derr D; Hildreth JE
J Immunol; 1992 Oct; 149(8):2549-59. PubMed ID: 1383318
[TBL] [Abstract][Full Text] [Related]
17. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
Tedder TF; Tuscano J; Sato S; Kehrl JH
Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
[TBL] [Abstract][Full Text] [Related]
18. SC3 monoclonal antibody defines a novel specific human B-cell surface antigen differentially expressed on B-cell leukaemias and lymphomas and involved in the proliferation of normal and malignant B lymphocytes.
Nikolova M; Guenova M; Taskov H; Marie-Cardine A; Boumsell L; Bensussan A
Cell Immunol; 2005; 236(1-2):92-100. PubMed ID: 16197933
[TBL] [Abstract][Full Text] [Related]
19. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor.
Sato S; Tuscano JM; Inaoki M; Tedder TF
Semin Immunol; 1998 Aug; 10(4):287-97. PubMed ID: 9695185
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
